Role for μ-opioid receptor in antidepressant effects of δ-opioid receptor agonist KNT-127

J Pharmacol Sci. 2023 Mar;151(3):135-141. doi: 10.1016/j.jphs.2022.12.008. Epub 2022 Dec 28.

Abstract

Previous pharmacological data have shown the possible existence of functional interactions between μ- (MOP), κ- (KOP), and δ-opioid receptors (DOP) in pain and mood disorders. We previously reported that MOP knockout (KO) mice exhibit a lower stress response compared with wildtype (WT) mice. Moreover, DOP agonists have been shown to exert antidepressant-like effects in numerous animal models. In the present study, the tail suspension test (TST) and forced swim test (FST) were used to examine the roles of MOP and DOP in behavioral despair. MOP-KO mice and WT mice were treated with KNT-127 (10 mg/kg), a selective DOP agonist. The results indicated a significant decrease in immobility time in the KNT-127 group compared with the saline group in all genotypes in both tests. In the saline groups, immobility time significantly decreased in MOP-KO mice compared with WT mice in both tests. In female MOP-KO mice, KNT-127 significantly decreased immobility time in the TST compared with WT mice. In male MOP-KO mice, however, no genotypic differences were found in the TST after either KNT-127 or saline treatment. Thus, at least in the FST and TST, the activation of DOP and absence of MOP had additive effects in reducing measures of behavioral despair, suggesting that effects on this behavior by DOP activation occur independently of MOP.

Keywords: Antidepressant; Anxiolytic; Lack of motivated behavior; δ-opioid receptor agonist; μ-opioid receptor.

MeSH terms

  • Analgesics, Opioid / pharmacology
  • Animals
  • Antidepressive Agents / pharmacology
  • Female
  • Male
  • Mice
  • Morphinans* / pharmacology
  • Pain / drug therapy
  • Receptors, Opioid, mu*

Substances

  • KNT 127
  • Receptors, Opioid, mu
  • Morphinans
  • Antidepressive Agents
  • Analgesics, Opioid